Microneedle patches for vaccination in developing countries.

Millions of people die of infectious diseases each year, mostly in developing countries, which could largely be prevented by the use of vaccines. While immunization rates have risen since the introduction of the Expanded Program on Immunization (EPI), there remain major challenges to more effective vaccination in developing countries. As a possible solution, microneedle patches containing an array of micron-sized needles on an adhesive backing have been developed to be used for vaccine delivery to the skin. These microneedle patches can be easily and painlessly applied by pressing against the skin and, in some designs, do not leave behind sharps waste. The patches are single-dose, do not require reconstitution, are easy to administer, have reduced size to simplify storage, transportation and waste disposal, and offer the possibility of improved vaccine immunogenicity, dose sparing and thermostability. This review summarizes vaccination challenges in developing countries and discusses advantages that microneedle patches offer for vaccination to address these challenges. We conclude that microneedle patches offer a powerful new technology that can enable more effective vaccination in developing countries.

[1]  S. Nakagawa,et al.  Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease , 2014, Journal of Neuroimmunology.

[2]  J. Stockman,et al.  Dissolving polymer microneedle patches for influenza vaccination , 2012 .

[3]  A. Crean,et al.  Microneedle Array Design Determines the Induction of Protective Memory CD8+ T Cell Responses Induced by a Recombinant Live Malaria Vaccine in Mice , 2011, PloS one.

[4]  Mark R. Prausnitz,et al.  Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine , 2012, PloS one.

[5]  Mark R Prausnitz,et al.  Microneedle patches: usability and acceptability for self-vaccination against influenza. , 2014, Vaccine.

[6]  Ying Zhang,et al.  Development of Lidocaine-Coated Microneedle Product for Rapid, Safe, and Prolonged Local Analgesic Action , 2011, Pharmaceutical Research.

[7]  Mark R Prausnitz,et al.  Development of a thermostable microneedle patch for influenza vaccination. , 2015, Journal of pharmaceutical sciences.

[8]  J. Hooper,et al.  Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge , 2006, Vaccine.

[9]  N. Mickuvienė,et al.  Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial , 2009, BMC medicine.

[10]  Frank O. Nestle,et al.  Skin immune sentinels in health and disease , 2009, Nature Reviews Immunology.

[11]  W. Jiskoot,et al.  Immune Modulation by Adjuvants Combined with Diphtheria Toxoid Administered Topically in BALB/c Mice After Microneedle Array Pretreatment , 2009, Pharmaceutical Research.

[12]  M. Kermode Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. , 2004, Health promotion international.

[13]  M. Prausnitz,et al.  Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[14]  I. Frazer,et al.  Skin Vaccination against Cervical Cancer Associated Human Papillomavirus with a Novel Micro-Projection Array in a Mouse Model , 2010, PloS one.

[15]  I. Frazer,et al.  Increasing mechanical stimulus induces migration of Langerhans cells and impairs the immune response to intracutaneously delivered antigen , 2011, Experimental dermatology.

[16]  M. Prausnitz,et al.  A microneedle patch containing measles vaccine is immunogenic in non-human primates. , 2015, Vaccine.

[17]  P. Lydon,et al.  Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade? , 2014, Bulletin of the World Health Organization.

[18]  M. Sawhney,et al.  Why children are not vaccinated: a review of the grey literature. , 2012, International health.

[19]  P. van Damme,et al.  Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. , 2009, Vaccine.

[20]  Y. Levin,et al.  Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same? , 2014, Vaccine.

[21]  M. Kendall,et al.  DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge. , 2010, Vaccine.

[22]  M. Prausnitz,et al.  Bacillus Calmette-Guérin vaccination using a microneedle patch. , 2011, Vaccine.

[23]  I. Frazer,et al.  Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Mark R. Prausnitz,et al.  Stability of influenza vaccine coated onto microneedles. , 2012, Biomaterials.

[25]  R. Fields,et al.  Drivers of routine immunization coverage improvement in Africa: findings from district-level case studies , 2014, Health policy and planning.

[26]  Mark R. Prausnitz,et al.  Intradermal Vaccination with Influenza Virus-Like Particles by Using Microneedles Induces Protection Superior to That with Intramuscular Immunization , 2010, Journal of Virology.

[27]  Mark R. Prausnitz,et al.  Local Response to Microneedle-Based Influenza Immunization in the Skin , 2012, mBio.

[28]  J. Díez-Domingo,et al.  Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: a comparative effectiveness study using the Valencia health care information system. , 2014, Vaccine.

[29]  R. Compans,et al.  Host Responses in Human Skin After Conventional Intradermal Injection or Microneedle Administration of Virus‐Like‐Particle Influenza Vaccine , 2013, Advanced healthcare materials.

[30]  James C. Birchall,et al.  Microneedles in Clinical Practice–An Exploratory Study Into the Opinions of Healthcare Professionals and the Public , 2010, Pharmaceutical Research.

[31]  M. Prausnitz,et al.  Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque. , 2015, Vaccine.

[32]  S. Madhi,et al.  Effect of human rotavirus vaccine on severe diarrhea in African infants. , 2010, The New England journal of medicine.

[33]  K. Ahmad MSF tuberculosis report criticises DOTS strategy. , 2004, The Lancet. Infectious diseases.

[34]  G. Ippolito,et al.  Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007 , 2009, BMC medicine.

[35]  W. Jiskoot,et al.  Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array , 2010, Pharmaceutical Research.

[36]  Yuqin Qiu,et al.  Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays , 2013, Biomedical Microdevices.

[37]  F. de Looze,et al.  Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. , 2008, The Journal of infectious diseases.

[38]  N. Harvey,et al.  Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines , 2007, Clinical and Vaccine Immunology.

[39]  M. Prausnitz,et al.  Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[40]  Leonard A. Smith,et al.  An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock , 2008, Journal of immune based therapies and vaccines.

[41]  M. Prausnitz,et al.  Measles vaccination using a microneedle patch. , 2013, Vaccine.

[42]  Mark R Prausnitz,et al.  Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. , 2010, Vaccine.

[43]  M. Prausnitz,et al.  Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection , 2012, Scientific Reports.

[44]  Shawn T. Brown,et al.  ne size does not fit all : The impact of primary vaccine container size n vaccine distribution and delivery , 2015 .

[45]  W. Jiskoot,et al.  Microneedle-Based Transcutaneous Immunisation in Mice with N-Trimethyl Chitosan Adjuvanted Diphtheria Toxoid Formulations , 2010, Pharmaceutical Research.

[46]  M. Prausnitz,et al.  Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse Skin , 2009, PloS one.

[47]  Cheryl H. Dean,et al.  Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates , 2005, Human vaccines.

[48]  C. Sudfeld,et al.  Effectiveness of measles vaccination and vitamin A treatment , 2010, International journal of epidemiology.

[49]  Ryan F. Donnelly,et al.  Hydrogel-Forming Microneedle Arrays Can Be Effectively Inserted in Skin by Self-Application: A Pilot Study Centred on Pharmacist Intervention and a Patient Information Leaflet , 2014, Pharmaceutical Research.

[50]  Dexiang Chen,et al.  Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[51]  P. Drain,et al.  Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries. , 2003, Bulletin of the World Health Organization.

[52]  Vincent J. Sullivan,et al.  Microneedle-Based Intradermal Delivery of the Anthrax Recombinant Protective Antigen Vaccine , 2006, Infection and Immunity.

[53]  Hervé Bourhy,et al.  Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. , 2010, Vaccine.

[54]  Thomas Hankemeier,et al.  Novel Hollow Microneedle Technology for Depth-Controlled Microinjection-Mediated Dermal Vaccination: A Study with Polio Vaccine in Rats , 2014, Pharmaceutical Research.

[55]  T. John,et al.  Efficacy of inactivated poliovirus vaccine in India. , 1983, Bulletin of the World Health Organization.

[56]  I. Frazer,et al.  Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model , 2010, PloS one.

[57]  Koen van der Maaden,et al.  Microneedle technologies for (trans)dermal drug and vaccine delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[58]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[59]  C. Goujon,et al.  Nine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults , 2014, Human vaccines & immunotherapeutics.

[60]  M. Miller,et al.  The cost of unsafe injections. , 1999, Bulletin of the World Health Organization.

[61]  P. Das Revolutionary vaccine technology breaks the cold chain. , 2004, The Lancet. Infectious diseases.

[62]  T. Denning,et al.  Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts , 2015, Vaccine.

[63]  M. Prausnitz,et al.  Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. , 2013, Vaccine.

[64]  Yang Yang,et al.  Advanced Materials and Nanotechnology for Drug Delivery , 2014, Advanced materials.

[65]  Corona M. Cassidy,et al.  Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[66]  F. Geissmann,et al.  Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays , 2013, Proceedings of the National Academy of Sciences.

[67]  Angela K. Shen,et al.  The future of routine immunization in the developing world: challenges and opportunities , 2014, Global Health: Science and Practice.

[68]  Mathias Currat,et al.  Impact of Selection and Demography on the Diffusion of Lactase Persistence , 2009, PloS one.

[69]  K. Brehm,et al.  Characterization of S3Pvac Anti-Cysticercosis Vaccine Components: Implications for the Development of an Anti-Cestodiasis Vaccine , 2010, PLoS ONE.

[70]  Conor O'Mahony,et al.  Coated microneedle arrays for transcutaneous delivery of live virus vaccines. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[71]  L. Babiuk,et al.  Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization , 2009, Proceedings of the National Academy of Sciences.

[72]  Kyoung-Mi Park,et al.  Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. , 2010, Antiviral research.

[73]  J. Matriano,et al.  Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women. , 2010, The Journal of clinical endocrinology and metabolism.

[74]  Yohei Mukai,et al.  Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[75]  M. Prausnitz,et al.  Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge , 2009, Proceedings of the National Academy of Sciences.

[76]  Vincent J. Sullivan,et al.  Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. , 2005, The Journal of infectious diseases.

[77]  Yuxiao Tang,et al.  Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. , 2011, Bulletin of the World Health Organization.

[78]  G. Kang,et al.  Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial , 2014, The Lancet.

[79]  S. Gorman,et al.  Microneedle-mediated transdermal bacteriophage delivery , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[80]  M. Prausnitz,et al.  A protective role of murine langerin+ cells in immune responses to cutaneous vaccination with microneedle patches , 2014, Scientific Reports.

[81]  M. Prausnitz,et al.  Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine , 2010, Gene Therapy.

[82]  Zhixian Gao,et al.  Hepatitis B DNA vaccine-polycation nano-complexes enhancing immune response by percutaneous administration with microneedle. , 2013, Biological & pharmaceutical bulletin.

[83]  Mark R Prausnitz,et al.  Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[84]  J. Heyse,et al.  Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.

[85]  M. Prausnitz,et al.  Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. , 2010, The Journal of infectious diseases.

[86]  Ramon Kaneno,et al.  Efficiency of colon cancer RNA-transfected DC vaccine is enhanced by previous treatment of tumor cells with low concentration of 5-fluorouracil , 2012 .

[87]  F. Fenner Smallpox and its eradication , 1988 .

[88]  Diane E. Sutter,et al.  Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.

[89]  B. Bloom,et al.  Drying a tuberculosis vaccine without freezing , 2007, Proceedings of the National Academy of Sciences.

[90]  P. Dormitzer,et al.  Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. , 2013, Vaccine.

[91]  Christophe Fraser,et al.  New Strategies for the Elimination of Polio from India , 2006, Science.

[92]  Seajin Oh,et al.  Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. , 2012, Journal of pharmaceutical sciences.

[93]  F. Ansaldi,et al.  Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system , 2012, Human vaccines & immunotherapeutics.

[94]  Bruce Y. Lee,et al.  An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine. , 2015, Vaccine.

[95]  R. Linkins,et al.  Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt. , 1995, Bulletin of the World Health Organization.

[96]  M. Prausnitz,et al.  Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[97]  Vincent J. Sullivan,et al.  Protective Immunity in Mice Achieved with Dry Powder Formulation and Alternative Delivery of Plague F1-V Vaccine , 2009, Clinical and Vaccine Immunology.

[98]  J. Bouwstra,et al.  Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[99]  R. Pettis,et al.  Microneedle delivery: clinical studies and emerging medical applications. , 2012, Therapeutic delivery.

[100]  C. O’Mahony,et al.  Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route , 2014, Scientific Reports.

[101]  Mark R Prausnitz,et al.  Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[102]  M. Prausnitz,et al.  Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Drying and Storage , 2010, Pharmaceutical Research.

[103]  M. Ameri,et al.  Effect of irradiation on parathyroid hormone PTH(1-34) coated on a novel transdermal microprojection delivery system to produce a sterile product--adhesive compatibility. , 2010, Journal of pharmaceutical sciences.

[104]  Gordon Larsen,et al.  Technologies that make administration of vaccines safer. , 2004, Vaccine.

[105]  A. Vrdoljak Review of recent literature on microneedle vaccine delivery technologies , 2013 .

[106]  Michael S Roberts,et al.  Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. , 2010, Small.

[107]  D. Zehrung,et al.  Intradermal delivery for vaccine dose sparing: overview of current issues. , 2013, Vaccine.